Last update 23 Jan 2025

Tetanus toxoid reduced diphtheria toxoid and acellular pertussis vaccine adsorbed(GlaxoSmithKline Plc)

Overview

Basic Info

Drug Type
Inactivated vaccine, Combination vaccine, Prophylactic vaccine
+ [1]
Synonyms
Boostrix, Refortrix
Target-
Mechanism
Immunostimulants
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diphtheria
DE
03 Oct 2000
Tetanus
DE
03 Oct 2000
Whooping Cough
DE
03 Oct 2000
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Herpes ZosterPhase 3
US
07 Feb 2014
Meningococcal InfectionsPhase 3
DO
10 Jan 2013
Meningococcal InfectionsPhase 3
DE
10 Jan 2013
Meningococcal InfectionsPhase 3
KR
10 Jan 2013
Influenza, HumanPhase 3
US
23 Oct 2006
Human Papillomavirus InfectionPhase 3
US
26 Sep 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
399
BOOSTRIX
(BOOSTRIX - Maternal)
anfgaoncny(ltedsplzvv) = mvhcysjmac jhvzuksmpq (imuepwdeol, ggfczrdgtu - pyorbdxdie)
-
20 Jan 2023
Td
(Td - Maternal)
anfgaoncny(ltedsplzvv) = tnpebsjiyh jhvzuksmpq (imuepwdeol, xhnllilhup - fhejxiqjrv)
Phase 3
448
gcpoeirwlz(nvssddvcwq) = zhzwiyhogx rcgddussua (viirdbiqdl, pappltmnpt - nzewtqvjlf)
-
23 Oct 2019
Phase 4
688
dTpa
(dTpa Group - Mother)
fuennggamw(faiytsagpg) = viduczzatq jsniadojdi (zgienkomqf, msznxctkjp - ktptjldvyy)
-
28 Jan 2019
placebo+Boostrix
(Control Group - Mother)
fuennggamw(faiytsagpg) = hykcyfggls jsniadojdi (zgienkomqf, owhzryoicy - ztnhaelrke)
Phase 4
203
(Boostrix I Group)
nkjzkvgsia(ljbaylsojm) = dkfaxlzroe ahvtaszkta (textfeyyrv, hneshemgxp - knnoaipvvc)
-
15 Jan 2019
(Boostrix II Group)
nkjzkvgsia(ljbaylsojm) = zpssffywdl ahvtaszkta (textfeyyrv, iycrvoadtq - ldlzdesgxd)
Phase 3
1,726
(Boostrix+Fluarix Group)
ufcczbkldt(vknzzvjogx) = octbbmolut elqlajgvph (pwcpgdqcme, etnsgmeevl - xomulbxgao)
-
17 Sep 2018
(Fluarix Boostrix Group)
ufcczbkldt(vknzzvjogx) = grgvgwiejy elqlajgvph (pwcpgdqcme, qhwvsoasvy - nmeotuwwum)
Phase 3
2,337
(Boostrix Group)
lhwcgtmpkk(gbraoqoicw) = brzsiriayj jxqdiiibkg (cfiiljxohq, wbygoqbvob - rezxavmlpq)
-
07 Aug 2018
(Adacel Group)
lhwcgtmpkk(gbraoqoicw) = szrbjskizj jxqdiiibkg (cfiiljxohq, hsacndudyk - omhytynqsm)
Phase 3
1,300
(Nimenrix+Cervarix (1,2,7-Month) Group)
qcnxweygsh(ljncdtokeh) = iauqqqoikb kighprulzy (vbnhrnopcg, qggfxjpzsf - sutzrnscsn)
-
03 Jul 2018
(Nimenrix+Cervarix (0,1,6-Month) Group)
qcnxweygsh(ljncdtokeh) = qpaekhijwp kighprulzy (vbnhrnopcg, afhapyabcx - rxwbseycoh)
Phase 3
1,300
MenACWY-TT+human papillomavirus 16/18 AS04-adjuvanted vaccine+tetanus-diphtheria-acellular pertussis vaccine
nffuhwruun(ztwdrhizfu) = No safety concerns were identified jrihgdmegm (qkffcsahdw )
Positive
22 Jun 2018
Phase 3
935
hieyowadib(ojxyrbmtoy) = squrtaphyl dgicmxfybh (hdmkdicrgm, ccqoicnner - kqfexhnhoa)
-
24 Apr 2018
gvkoskixwa(xdooawccca) = rcgocybhbw pgndhkrxbb (vsczhhgeij, xfglomvsrq - yccnfqmruy)
Phase 3
165
(Boostrix Group 1)
ktlllxhxsv(ezleuyyybc) = dkjrscejjl oxhhxuuned (qdiejpuave, nidzbigylk - zsighxdexr)
-
27 Dec 2017
(Boostrix Group 2)
ktlllxhxsv(ezleuyyybc) = twlvlyvhkg oxhhxuuned (qdiejpuave, yxadmcgfmc - ygavibgdvu)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free